Lexicon Pharmaceuticals, Inc. (LXRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 186.03M | 101.89M | 122.53M | 145.08M | 245.81M | 246.19M | 268.61M | 320.84M | 364.65M | 176.55M | 223.37M | 263.72M |
| Cash & Short-Term Investments | 170.66M | 96.23M | 115.95M | 139.01M | 194.84M | 237.96M | 258.37M | 309.96M | 355.6M | 170.03M | 218.43M | 256.74M |
| Cash Only | 38.09M | 34.33M | 49.66M | 21.36M | 62.89M | 66.66M | 34.55M | 35.62M | 96.49M | 22.46M | 21.12M | 102.27M |
| Short-Term Investments | 132.57M | 61.9M | 66.29M | 117.64M | 131.95M | 171.3M | 223.82M | 274.35M | 259.1M | 147.56M | 197.31M | 154.47M |
| Accounts Receivable | 11.78M | 2.38M | 2.33M | 2.18M | 47.45M | 3.47M | 2.9M | 2.62M | 1.53M | 1.01M | 318K | 685K |
| Days Sales Outstanding | 30.2 | 39.51 | 14.65 | 78.23 | 1.82K | 11.03 | 144.97 | 114.54 | 102.11 | 87.02 | 284.8 | 135.78 |
| Inventory | 276K | 281K | 158K | 168K | 201K | 231K | 636K | 585K | 514K | 381K | 336K | 172K |
| Days Inventory Outstanding | 232.08 | 63.3 | 1.5K | 80.33 | 648 | 1.54 | 791.07 | 301.23 | 232.7 | 2.22 | 3.34K | 1.96K |
| Other Current Assets | 3.32M | 3M | 4.08M | 3.73M | 3.32M | 4.53M | 6.71M | 7.67M | 7.01M | 5.13M | 4.29M | 6.12M |
| Total Non-Current Assets | 82.79M | 83.09M | 83.4M | 80.5M | 51.87M | 52.23M | 52.52M | 52.51M | 52.57M | 52.88M | 53.11M | 53M |
| Property, Plant & Equipment | 8.88M | 9.18M | 9.49M | 6.59M | 6.95M | 7.32M | 7.15M | 7.14M | 7.2M | 7.51M | 7.82M | 8.46M |
| Fixed Asset Turnover | 2.34x | 0.59x | 1.76x | 4.26x | 0.18x | 3.67x | 0.24x | 0.23x | 0.15x | 0.09x | 0.02x | 0.04x |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 29.37M | 29.37M | 29.37M | 29.37M | 368K | 368K | 828K | 828K | 828K | 828K | 743K | 0 |
| Total Assets | 268.82M | 184.99M | 205.93M | 225.58M | 297.67M | 298.42M | 321.12M | 373.36M | 417.22M | 229.43M | 276.48M | 316.72M |
| Asset Turnover | 0.09x | 0.03x | 0.07x | 0.11x | 0.00x | 0.09x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -9.69% | -38.01% | -35.87% | -39.58% | -28.65% | 30.07% | 16.15% | 17.88% | 156.41% | 18.08% | 44.24% | 181.97% |
| Total Current Liabilities | 9.9M | 20.87M | 21.72M | 34.84M | 110.69M | 45.25M | 36.05M | 27.88M | 23.4M | 31.55M | 32.26M | 26.11M |
| Accounts Payable | 3M | 3.08M | 3.8M | 5.9M | 10.69M | 14.8M | 14.2M | 12.22M | 8.07M | 14.39M | 12.04M | 10.5M |
| Days Payables Outstanding | 2.53K | 992.1 | 44.6K | 3.61K | 38.23K | 51.44 | 17.12K | 5.56K | 5.84K | 81.95 | 148.1K | 118.37K |
| Short-Term Debt | 1.64M | 6.24M | 0 | 0 | 42.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 4.3M | 17.46M | 45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.26M | 11.55M | 4.79M | 4.29M | 3.77M | 14.71M | 11.17M | 0 | 0 | 0 | 9.77M | 7.57M |
| Current Ratio | 18.79x | 4.88x | 5.64x | 4.16x | 2.22x | 5.44x | 7.45x | 11.51x | 15.58x | 5.60x | 6.92x | 10.10x |
| Quick Ratio | 18.77x | 4.87x | 5.63x | 4.16x | 2.22x | 5.44x | 7.43x | 11.49x | 15.56x | 5.58x | 6.91x | 10.09x |
| Cash Conversion Cycle | -2.27K | -889.29 | -43.09K | -3.45K | -35.77K | -38.87 | -16.18K | -5.14K | -5.5K | 7.29 | -144.48K | -116.28K |
| Total Non-Current Liabilities | 56.06M | 56.58M | 64.05M | 61.31M | 63.95M | 107.22M | 106.56M | 105.5M | 104.95M | 104.77M | 104.71M | 104.25M |
| Long-Term Debt | 49.68M | 49.41M | 56.51M | 56.11M | 58.64M | 100.3M | 99.89M | 99.5M | 99.87M | 99.51M | 99.27M | 98.77M |
| Capital Lease Obligations | 6.38M | 6.59M | 0 | 0 | 0 | 6.92M | 0 | 4.89M | 5.08M | 5.26M | 5.44M | 5.48M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 582K | 7.54M | 5.2M | 5.3M | 0 | 6.67M | 1.11M | 0 | 0 | 0 | 0 |
| Total Liabilities | 65.96M | 77.45M | 85.77M | 96.14M | 174.64M | 152.47M | 142.61M | 133.38M | 128.35M | 136.32M | 136.97M | 130.36M |
| Total Debt | 57.71M | 62.24M | 58.15M | 57.02M | 101.74M | 108.4M | 101.2M | 105.68M | 106.24M | 106.06M | 106M | 105.55M |
| Net Debt | 19.62M | 27.91M | 8.49M | 35.65M | 38.85M | 41.74M | 66.64M | 70.06M | 9.75M | 83.6M | 84.88M | 3.27M |
| Debt / Equity | 0.28x | 0.58x | 0.48x | 0.44x | 0.83x | 0.74x | 0.57x | 0.44x | 0.37x | 1.14x | 0.76x | 0.57x |
| Debt / EBITDA | - | - | - | 14.57x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | 9.11x | - | - | - | - | - | - | - | - |
| Interest Coverage | -0.63x | -7.28x | -4.93x | 2.40x | -12.78x | -5.30x | -13.21x | -23.17x | -9.01x | -8.36x | -11.96x | -21.91x |
| Total Equity | 202.86M | 107.54M | 120.16M | 129.44M | 123.03M | 145.95M | 178.51M | 239.98M | 288.87M | 93.11M | 139.51M | 186.36M |
| Equity Growth % | 64.88% | -26.32% | -32.69% | -46.06% | -57.41% | 56.75% | 27.96% | 28.77% | 228.09% | -20.5% | -3.13% | 163.11% |
| Book Value per Share | 0.51 | 0.30 | 0.33 | 0.36 | 0.34 | 0.40 | 0.49 | 0.77 | 1.18 | 0.38 | 0.57 | 0.91 |
| Total Shareholders' Equity | 202.86M | 107.54M | 120.16M | 129.44M | 123.03M | 145.95M | 178.51M | 239.98M | 288.87M | 93.11M | 139.51M | 186.36M |
| Common Stock | 426K | 366K | 366K | 366K | 366K | 363K | 363K | 363K | 248K | 245K | 245K | 245K |
| Retained Earnings | -2.02B | -2.02B | -2B | -1.99B | -1.99B | -1.97B | -1.93B | -1.87B | -1.82B | -1.77B | -1.72B | -1.67B |
| Treasury Stock | -2.84M | -5.19M | -5.19M | -5.19M | -5.19M | -4.62M | -4.62M | -4.62M | -4.62M | -2.88M | -2.88M | -2.88M |
| Accumulated OCI | -130K | 30K | 29K | -14K | 25K | 119K | 349K | -193K | -50K | 31K | -113K | -100K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |